Philochem

Philochem is a Swiss subsidiary of the Philogen group (www.philogen.com), acting as discovery center for the group. Philochem’s activities focus on chemical pharmaceutical products and technologies. Read all

NEWS

Philogen S.p.A. will announce its maiden First Quarter 2021 Results on Wednesday 12th May 2021 A virtual briefing will be hosted for sell-side analysts at 10:00am EST / 14:00pm BST / 15:00pm...

Read all

PIPELINE

Philochem complements the pipeline of Philogen (which focuses on antibody products) with pharmaceutical products based on small organic molecules. Read all

PARTNERS

Over the years the Philogen group has developed products and technologies in collaboration with leading pharmaceutical companies, including:

Philochem is a fully-owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner or continuing to browse, you agree to the use of cookies.

I Accept Cookie Policy